Clever Stock

clever.comEducation / Education softwareFounded: 2012Funding to Date: $59.95MM

Clever is the developer of digital learning solutions that bring all applications into one secure portal and provides single sign-on for everyone in the district.

Register To Buy and Sell Shares

For more details on financing and valuation for Clever, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Clever’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Clever.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Tyler Bosmeny
Co-Founder, Chief Executive Officer & Board Member
Rafael Garcia
Chief Technology Officer & Co-Founder
Daniel Carroll
Co-Founder & Chief Product Officer

Board Members

Tyler Bosmeny
Bryan Schreier
Sequoia Capital
Ravi Mhatre
Lightspeed Venture Partners

News Highlights

Ed Tech Company Kahoot! Acquires Clever for $500M
Global ed tech company Kahoot! has announced its plans to purchase digital learning platform Clever Inc. The partnership will join together two digital learning giants, and expand the use of Clever globally.
Clever Care Health Plan launches with a holistic healing spin on Medicare Advantage programs
Angling for a slice of the multi-billion dollar Medicare Advantage market with a pitch to integrate holistic medical practitioners into its network of service providers has netted Clever Care Health Plan some big backers and a huge market opportunity, the company says. The company has raised $23 million
Clever Leaves Raises US$14M in Series E Financing | FinSMEs
Clever Leaves International Inc., a multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, held the first closing of its Series E financing at US$14m
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.